Valuation : Allied Corp.

Market Cap 1.3M 1.12M 1.05M 962K 1.81M 124M 1.82M 12.48M 4.86M 62.78M 4.89M 4.79M 208M P/E 2023
-2.13x
P/E 2024 -2.52x
Enterprise Value 7.55M 6.5M 6.1M 5.57M 10.46M 719M 10.54M 72.3M 28.13M 364M 28.35M 27.73M 1.21B EV / Sales 2023
394,366,816x
EV / Sales 2024 171,944,593x
Free-Float
100%
Yield 2023 *
-
Yield 2024 -
1 month 0
Extreme 1.0E-6
0
Current year 0
Extreme 1.0E-6
0.01
1 year 0
Extreme 1.0E-6
0.01
3 years 0
Extreme 1.0E-6
0.25
5 years 0
Extreme 1.0E-6
2.15
10 years 0
Extreme 1.0E-6
4.5
Manager TitleAgeSince
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer 71 -
Corporate Officer/Principal - 2020-05-01
Director TitleAgeSince
Director/Board Member - -
Director/Board Member - 2020-05-01
Director/Board Member - 2024-10-20
Date Insider Type Main position Quantity % Market Cap. Importance
4/25/23 Buy

Director

80,000 0.0824%
9/22/20 Buy

Chief Executive Officer

10,000 0.0118%
9/22/20 Other

Chief Executive Officer

0 0%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 117
Average -.--%
Weighted average by Cap. -.--%

Financials

2023 2024
Net sales 0.07 0.06 0.06 0.05 0.1 6.86 0.1 0.69 0.27 3.47 0.27 0.26 11.52 0.1 0.08 0.08 0.07 0.13 9.15 0.13 0.92 0.36 4.63 0.36 0.35 15.36
Net income -10.68M -9.19M -8.62M -7.88M -14.79M -1.02B -14.9M -102M -39.78M -514M -40.08M -39.21M -1.71B -3.98M -3.42M -3.21M -2.94M -5.51M -378M -5.55M -38.07M -14.81M -191M -14.93M -14.6M -635M
Net Debt 5.65M 4.87M 4.57M 4.17M 7.83M 538M 7.89M 54.11M 21.06M 272M 21.22M 20.76M 903M 6.25M 5.38M 5.05M 4.61M 8.66M 594M 8.72M 59.82M 23.28M 301M 23.46M 22.95M 998M
Logo Allied Corp.
Allied Corp. is an international medical cannabis production company. The Company is engaged in researching, creating, and producing targeted cannabinoid health solutions. It focuses on the development of Colombian produced medicinal cannabis for patients with conditions potentially suitable for treatment. Such conditions include anxiety, insomnia, anorexia, chronic pain, epilepsy, chemotherapy-induced nausea and vomiting, post-traumatic stress disorder (PTSD), Parkinson’s disease, Tourette’s syndrome, irritable bowel syndrome (IBS) and spasticity associated with multiple sclerosis (MS) and spinal cord injury (SCI). Its core hemp-derived cannabidiol (CBD) brands are Tactical Relief Brand, Equilibrium Bio and MaXXa. The Tactical Relief brand's flagship product is a hemp-derived CBD tincture for sale in the United States. The Equilibrium Bio brand is primarily focused on hydration and recovery areas. The MaXXa brand develops natural CBD-infused cosmetics and beauty products.
Employees
-
  1. Stock Market
  2. Stocks
  3. ALID Stock